96 related articles for article (PubMed ID: 1361526)
1. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas.
Poller DN; Spendlove I; Baker C; Church R; Ellis IO; Plowman GD; Mayer RJ
J Pathol; 1992 Nov; 168(3):275-80. PubMed ID: 1361526
[TBL] [Abstract][Full Text] [Related]
2. Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.
Rajkumar T; Gooden CS; Lemoine NR; Gullick WJ; Goden CS
J Pathol; 1993 Jul; 170(3):271-8. PubMed ID: 8133400
[TBL] [Abstract][Full Text] [Related]
3. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
4. The production and characterisation of monoclonal antibodies to myc, c-erbB-2 and EFG-receptor using a synthetic peptide approach.
Price KM; Cuthbertson AS; Varndell IM; Sheppard PW
Dev Biol Stand; 1990; 71():23-31. PubMed ID: 1698166
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study.
Falck VG; Gullick WJ
J Pathol; 1989 Oct; 159(2):107-11. PubMed ID: 2572685
[TBL] [Abstract][Full Text] [Related]
7. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
[TBL] [Abstract][Full Text] [Related]
8. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.
D'Emilia J; Bulovas K; D'Ercole K; Wolf B; Steele G; Summerhayes IC
Oncogene; 1989 Oct; 4(10):1233-9. PubMed ID: 2571966
[TBL] [Abstract][Full Text] [Related]
10. Expression of the c-erbB-3 protein in normal human adult and fetal tissues.
Prigent SA; Lemoine NR; Hughes CM; Plowman GD; Selden C; Gullick WJ
Oncogene; 1992 Jul; 7(7):1273-8. PubMed ID: 1377811
[TBL] [Abstract][Full Text] [Related]
11. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
Giatromanolaki A; Gorgoulis V; Chetty R; Koukourakis MI; Whitehouse R; Kittas C; Veslemes M; Gatter KC; Iordanoglou I
Anticancer Res; 1996; 16(2):987-93. PubMed ID: 8687165
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
13. Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization.
Ooi A; Kobayashi M; Mai M; Nakanishi I
Lab Invest; 1998 Mar; 78(3):345-51. PubMed ID: 9520947
[TBL] [Abstract][Full Text] [Related]
14. C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells.
Mori S; Akiyama T; Yamada Y; Morishita Y; Sugawara I; Toyoshima K; Yamamoto T
Lab Invest; 1989 Jul; 61(1):93-7. PubMed ID: 2473278
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
[TBL] [Abstract][Full Text] [Related]
17. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study.
Kernohan NM; Blessing K; King G; Corbett IP; Miller ID
J Pathol; 1991 Jan; 163(1):77-80. PubMed ID: 1672154
[TBL] [Abstract][Full Text] [Related]
19. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
[TBL] [Abstract][Full Text] [Related]
20. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
